Blood-retinal barrier: The fundamentals

Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems

Volumn , Issue , 2012, Pages 111-132

  Fernandes, Rosa ^a   Gonçalves, Andreia ^a   Cunha Vaz, José ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903480502     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12950     Document Type: Chapter

References (122)

1. Adachi, M., Inoko, A., Hata, M. et al. 2006. Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein. Mol Cell Biol, 26, 9003-9015.
2. Alm, A. and Tornquist, P. 1985. Lactate transport through the blood-retinal and the blood-brain barrier in rats. Ophthalmic Res, 17, 181-184.
3. Altenberg, G. A. 2004. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily. Curr Med Chem Anticancer Agents, 4, 53-62.
4. Antcliff, R. J. and Marshall, J. 1999. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol, 14, 223-232.
5. Antonetti, D. A., Barber, A. J., Hollinger, L. A. et al. 1999. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem, 274, 23463-23467.
6. Arrate, M. P., Rodriguez, J. M., Tran, T. M. et al. 2001. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem, 276, 45826-45832.
7. Asashima, T., Hori, S., Ohtsuki, S. et al. 2006. ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells. Pharm Res, 23, 1235-1242.
8. Ashton, N. and Cunha-Vaz, J. G. 1965. Effect of histamine on the permeability of the ocular vessels. Arch Ophthalmol, 73, 211-223.
9. Aurrand-Lions, M., Duncan, L., Ballestrem, C. et al. 2001. JAM-2, a novel immunoglobu-lin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem, 276, 2733-2741.
10. Badr, G. A., Tang, J., Ismail-Beigi, F. et al. 2000. Diabetes downregulates GLUT1 expres-sion in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes, 49, 1016-1021.
11. Baldwin, S. A., Beal, P. R., Yao, S. Y. et al. 2004. The equilibrative nucleoside transporter fam-ily, SLC29. Pflugers Arch, 447, 735-743.
12. Barber, A. J. and Antonetti, D. A. 2003. Mapping the blood vessels with paracellular perme-ability in the retinas of diabetic rats. Invest Ophthalmol Vis Sci, 44, 5410-5416.
13. Bauer, A. T., Burgers, H. F., Rabie, T. et al. 2010. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab, 30, 837-848.
14. Bauer, H. C., Traweger, A., Zweimueller-Mayer, J. et al. 2011. New aspects of the molecular constituents of tissue barriers. J Neural Transm, 118, 7-21.
15. Bernardes, R., Santos, T., Serranho, P. et al. 2011. Noninvasive evaluation of retinal leakage using optical coherence tomography. Ophthalmologica, 226, 29-36.
16. Betz, A. L. and Goldstein, G. W. 1980. Transport of hexoses, potassium and neutral amino acids into capillaries isolated from bovine retina. Exp Eye Res, 30, 593-605.
17. Bhaskar, P. A., Vanchilingam, S., Bhaskar, E. A. et al. 1986. Effect of l-dopa on visual evoked potential in patients with Parkinson’s disease. Neurology 36:1119-1121.
18. Bito, L. Z. 1977. The physiology and pathophysiology of intraocular fluids. Exp Eye Res 25 (Suppl):273-289.
19. Boulton, M., Rozanowska, M., and Rozanowski, B. 2001. Retinal photodamage. J Photochem Photobiol B, 64, 144-161.
20. Bridges, C. C., Kekuda, R., Wang, H. et al. 2001. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci, 42, 47-54.
21. Caplan, M. J., Seo-Mayer, P., and Zhang, L. 2008. Epithelial junctions and polarity: Complexes and kinases. Curr Opin Nephrol Hypertens, 17, 506-512.
22. Cereijido, M., Contreras, R. G., Shoshani, L. et al. 2008. Tight junction and polarity interac-tion in the transporting epithelial phenotype. Biochim Biophys Acta, 1778, 770-793.
23. Colegio, O. R., Van Itallie, C. M., McCrea, H. J. et al. 2002. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 283:C142-147.
24. Cunha-Vaz, J. G. F. D. 1965. Permeability of the retinal vessels in health and disease. London: University of London (Institute of Ophthalmology).
25. Cunha-Vaz, J. G. 1966. Studies on the permeability of the blood-retinal barrier. 3. Breakdown of the blood-retinal barrier by circulatory disturbances. Br J Ophthalmol, 50, 505-516.
26. Cunha-Vaz J. G. 1997. Optical sensors for clinical ocular fluorometry. Prog Ret Eye Res, 16, 243-270.
27. Cunha-Vaz, J., Faria de Abreu, J. R., and Campos, A. J. 1975. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol, 59, 649-656.
28. Cunha-Vaz, J. G. and Maurice, D. M. 1967. The active transport of fluorescein by the retinal vessels and the retina. J Physiol, 191, 467-486.
29. Cunha-Vaz, J. G., Shakib, M., and Ashton, N. 1966. Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier. Br J Ophthalmol, 50, 441-453.
30. Cunningham, S. A., Arrate, M. P., Rodriguez, J. M. et al. 2000. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J Biol Chem, 275, 34750-34756.
31. Dean, M., Rzhetsky, A., and Allikmets, R. 2001. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res, 11, 1156-1166.
32. Ebnet, K., Aurrand-Lions, M., Kuhn, A. et al. 2003. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: A possible role for JAMs in endothelial cell polarity. J Cell Sci, 116, 3879-3891.
33. Fanning, A. S., Jameson, B. J., Jesaitis, L. A. et al. 1998. The tight junction protein ZO-1 estab-lishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem, 273, 29745-29753.
34. Feldman, G. J., Mullin, J. M., and Ryan, M. P. 2005. Occludin: Structure, function and regula-tion. Adv Drug Deliv Rev, 57, 883-917.
35. Fernandes, R., Carvalho, A. L., Kumagai, A. et al. 2004. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation. Mol Vis, 10, 618-628.
36. Fernandes, R., Suzuki, K., and Kumagai, A. K. 2003. Inner blood-retinal barrier GLUT1 in long-term diabetic rats: An immunogold electron microscopic study. Invest Ophthalmol Vis Sci, 44, 3150-3154.
37. Fojo, A. T., Ueda, K., Slamon, D. J. et al. 1987. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A, 84, 265-269.
38. Forster, C. 2008. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol, 130, 55-70.
39. Furuse, M., Fujita, K., Hiiragi, T. et al. 1998a. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539-1550.
40. Furuse, M., Furuse, K., Sasaki, H. et al. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol, 153, 263-272.
41. Furuse, M., Itoh, M., Hirase, T. et al. 1994. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol, 127, 1617-1626.
42. Furuse, M., Hirase, T., Itoh, M. et al. 1993. Occludin: A novel integral membrane protein localizing at tight junctions. J Cell Biol, 123, 1777-1788.
43. Furuse, M., Sasaki, H., Fujimoto, K. et al. 1998b. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol, 143, 391-401.
44. Furuse, M., Sasaki, H., and Tsukita, S. 1999. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol, 147, 891-903.
45. Gao, B., Wenzel, A., Grimm, C. et al. 2002. Localization of organic anion transport pro-tein 2 in the apical region of rat retinal pigment epithelium. Invest Ophthalmol Vis Sci, 43, 510-514.
46. Gardner, T. W., Antonetti, D. A., Barber, A. J. et al. 2002. Diabetic retinopathy: More than meets the eye. Surv Ophthalmol 47 Suppl 2:S253-262.
47. Gerhart, D. Z., Leino, R. L., and Drewes, L. R. 1999. Distribution of monocarboxylate trans-porters MCT1 and MCT2 in rat retina. Neuroscience, 92, 367-375.
48. Ghiardi, G. J., Gidday, J. M., and Roth, S. 1999. The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vision Res, 39, 2519-2535.
49. Goldmann, E. E. 1913. Vitalbarfung am Zentralnervensystem. Abhandl. Konigl. Preuss Akad Wiss 1: 1-60.
50. Greenwood, J. 1992. Characterization of a rat retinal endothelial cell culture and the expres-sion of P-glycoprotein in brain and retinal endothelium in vitro. J Neuroimmunol, 39, 123-132.
51. Hagenbuch, B. and Meier, P. J. 2003. The superfamily of organic anion transporting polypep-tides. Biochim Biophys Acta, 1609, 1-18.
52. Haskins, J., Gu, L., Wittchen, E. S. et al. 1998. ZO-3, a novel member of the MAGUK pro-tein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol, 141, 199-208.
53. Heller-Stilb, B., van Roeyen, C., Rascher, K. et al. 2002. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J, 16, 231-233.
54. Hosoya, K., Kondo, T., Tomi, M. et al. 2001a. MCT1-mediated transport of l-lactic acid at the inner blood-retinal barrier: A possible route for delivery of monocarboxylic acid drugs to the retina. Pharm Res, 18, 1669-1676.
55. Hosoya, K., Saeki, S., and Terasaki, T. 2001b. Activation of carrier-mediated transport of l-cystine at the blood-brain and blood-retinal barriers in vivo. Microvasc Res, 62, 136-142.
56. Hosoya, K. and Tomi, M. 2005. Advances in the cell biology of transport via the inner blood-retinal barrier: Establishment of cell lines and transport functions. Biol Pharm Bull, 28, 1-8.
57. Hou, J., Gomes, A. S., Paul, D. L. et al. 2006. Study of claudin function by RNA interference. J Biol Chem, 281, 36117-36123.
58. Ikenouchi, J., Furuse, M., Furuse, K. et al. 2005. Tricellulin constitutes a novel barrier at tricel-lular contacts of epithelial cells. J Cell Biol, 171, 939-945.
59. Ikenouchi, J., Umeda, K., Tsukita, S. et al. 2007. Requirement of ZO-1 for the formation of belt-like adherens junctions during epithelial cell polarization. J Cell Biol, 176, 779-786.
60. Islas, S., Vega, J., Ponce, L. et al. 2002. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res, 274, 138-148.
61. Itoh, M., Morita, K., and Tsukita, S. 1999. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J Biol Chem 274:5981-5986.
62. Janzer, R. C. and Raff, M. C. 1987. Astrocytes induce blood-brain barrier properties in endo-thelial cells. Nature, 325, 253-257.
63. Kageyama, T., Nakamura, M., Matsuo, A. et al. 2000. The 4F2hc/LAT1 complex transports l-DOPA across the blood-brain barrier. Brain Res, 879, 115-121.
64. Kanai, Y., Segawa, H., Miyamoto, K. et al. 1998. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem, 273, 23629-23632.
65. Kaur, C., Foulds, W. S., and Ling, E. A. 2008. Blood-retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management. Prog Retin Eye Res, 27, 622-647.
66. Kim, J. H., Lee, Y. M., Ahn, E. M. et al. 2009. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. J Cereb Blood Flow Metab, 29, 1559-1567.
67. Klein R., Klein B. E., Moss S. E., et al. 1984. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology, 91, 1464-1474.
68. Krishnamurthy, P. and Schuetz, J. D. 2006. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol, 46, 381-410.
69. Kumagai, A. K., Vinores, S. A., and Pardridge, W. M. 1996. Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus. Brain Res, 706, 313-317.
70. LaNoue, K. F., Berkich, D. A., Conway, M. et al. 2001. Role of specific aminotransfer-ases in de novo glutamate synthesis and redox shuttling in the retina. J Neurosci Res, 66, 914-922.
71. Leal, E. C., Martins, J., Voabil, P. et al. 2010. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes, 59, 2637-2645.
72. Lepore, D., Molle, F., Pagliara, M. M. et al. 2011. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology, 118, 168-175.
73. Luo, Y., Xiao, W., Zhu, X. et al. 2011. Differential expression of claudins in retinas dur-ing normal development and the angiogenesis of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 52, 7556-7564.
74. Lutty, G. A. and McLeod, D. S. 2003. Retinal vascular development and oxygen-induced retinopathy: A role for adenosine. Prog Retin Eye Res, 22, 95-111.
75. Mandell, K. J., Babbin, B. A., Nusrat, A. et al. 2005. Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. J Biol Chem, 280, 11665-11674.
76. Mannermaa, E., Vellonen, K. S., and Urtti, A. 2006. Drug transport in corneal epithelium and blood-retina barrier: Emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev, 58, 1136-1163.
77. Mark, K. S. and Davis, T. P. 2002. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282:H1485-1494.
78. Martin-Padura, I., Lostaglio, S., Schneemann, M. et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junc-tions and modulates monocyte transmigration. J Cell Biol, 142, 117-127.
79. Matter, K., Aijaz, S., Tsapara, A. et al. 2005. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol, 17, 453-458.
80. Mellman, I. and Nelson, W. J. 2008. Coordinated protein sorting, targeting and distribution in polarized cells. Nat Rev Mol Cell Biol, 9, 833-845.
81. Minamizono, A., Tomi, M., and Hosoya, K. 2006. Inhibition of dehydroascorbic acid transport across the rat blood-retinal and -brain barriers in experimental diabetes. Biol Pharm Bull 29:2148-2150.
82. Morita, K., Furuse, M., Fujimoto, K. et al. 1999a. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A, 96, 511-516.
83. Morita, K., Sasaki, H., Furuse, M. et al. 1999b. Endothelial claudin: Claudin-5/TMVCF con-stitutes tight junction strands in endothelial cells. J Cell Biol, 147, 185-194.
84. Murakami, T., Felinski, E. A., and Antonetti, D. A. 2009. Occludin phosphorylation and ubiq-uitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem, 284, 21036-21046.
85. Nagase, K., Tomi, M., Tachikawa, M. et al. 2006. Functional and molecular characterization of adenosine transport at the rat inner blood-retinal barrier. Biochim Biophys Acta, 1758, 13-19.
86. Nakashima, T., Tomi, M., Katayama, K. et al. 2004. Blood-to-retina transport of creatine via creatine transporter (CRT) at the rat inner blood-retinal barrier. J Neurochem, 89, 1454-1461.
87. Nitta, T., Hata, M., Gotoh, S. et al. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol, 161, 653-660.
88. Palmeri, D., van Zante, A., Huang, C. C. et al. 2000. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercel-lular boundaries of endothelial cells. J Biol Chem, 275, 19139-19145.
89. Pasantes-Morales, H., Klethi, J., Ledig, M. et al. 1972. Free amino acids of chicken and rat retina. Brain Res, 41, 494-497.
90. Pasantes-Morales, H., Ochoa de la Paz, L. D., Sepulveda, J. et al. 1999. Amino acids as osmo-lytes in the retina. Neurochem Res, 24, 1339-1346.
91. Poitry-Yamate, C. L., Poitry, S., and Tsacopoulos, M. 1995. Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina. J Neurosci, 15, 5179-5191.
92. Pow, D. V. and Crook, D. K. 1995. Immunocytochemical evidence for the presence of high levels of reduced glutathione in radial glial cells and horizontal cells in the rabbit retina. Neurosci Lett, 193, 25-28.
93. Reese, T. S. and Karnovsky, M. J. 1967. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol, 34, 207-217.
94. Riazuddin, S., Ahmed, Z. M., Fanning, A. S. et al. 2006. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet, 79, 1040-1051.
95. Schutte, M. and Werner, P. 1998. Redistribution of glutathione in the ischemic rat retina. Neurosci Lett, 246, 53-56.
96. Shakib, M. and Cunha-Vaz, J. G. 1966. Studies on the permeability of the blood-retinal bar-rier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. Exp Eye Res, 5, 229-234.
97. Shen, J., Cross, S. T., Tang-Liu, D. D. et al. 2003. Evaluation of an immortalized retinal endo-thelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier. Pharm Res, 20, 1357-1363.
98. Steed, E., Balda, M. S., and Matter, K. 2010. Dynamics and functions of tight junctions. Trends Cell Biol, 20, 142-149.
99. Stevenson, B. R., Siliciano, J. D., Mooseker, M. S. et al. 1986. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol, 103, 755-766.
100. Sundstrom, J. M., Tash, B. R., Murakami, T. et al. 2009. Identification and analysis of occludin phosphosites: A combined mass spectrometry and bioinformatics approach. J Proteome Res, 8, 808-817.
101. Taylor A.W. 2011. Immunosuppressive and anti-inflammatory molecules that maintain immune privilege of the eye. In Immunology, Inflammation and Diseases of the Eye, ed. Darlene A Dartt, Reza Dana, Patricia D’Amore, Jerry Y. Niederkorn, pp. 44-49. Oxford:Elsevier.
102. Takata, K., Kasahara, T., Kasahara, M. et al. 1992. Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal bar-rier in the rat. Invest Ophthalmol Vis Sci, 33, 377-383.
103. Tomi, M., Funaki, T., Abukawa, H. et al. 2003. Expression and regulation of l-cystine transporter, system xc-, in the newly developed rat retinal Muller cell line (TR-MUL). Glia, 43, 208-217.
104. Tomi, M. and Hosoya, K. 2004. Application of magnetically isolated rat retinal vascular endothelial cells for the determination of transporter gene expression levels at the inner blood-retinal barrier. J Neurochem, 91, 1244-1248.
105. Tomi, M., Hosoya, K., Takanaga, H. et al. 2002. Induction of xCT gene expression and l-cystine transport activity by diethyl maleate at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci, 43, 774-779.
106. Tomi, M., Mori, M., Tachikawa, M. et al. 2005. l-type amino acid transporter 1-mediated l-leucine transport at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci, 46, 2522-2530.
107. Tomi, M., Tajima, A., Tachikawa, M. et al. 2008. Function of taurine transporter (Slc6a6/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells. Biochim Biophys Acta, 1778, 2138-2142.
108. Tomi, M., Terayama, T., Isobe, T. et al. 2007. Function and regulation of taurine transport at the inner blood-retinal barrier. Microvasc Res, 73, 100-106.
109. Tout, S., Chan-Ling, T., Hollander, H. et al. 1993. The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience, 55, 291-301.
110. Tsukita, S. and Furuse, M. 1999. Occludin and claudins in tight-junction strands: Leading or supporting players? Trends Cell Biol, 9, 268-273.
111. Tsukita, S., Furuse, M., and Itoh, M. 2001. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol, 2, 285-293.
112. Uchino, H., Kanai, Y., Kim, D. K. et al. 2002. Transport of amino acid-related compounds mediated by l-type amino acid transporter 1 (LAT1): Insights into the mechanisms of substrate recognition. Mol Pharmacol, 61, 729-737.
113. Umeda, K., Matsui, T., Nakayama, M. et al. 2004. Establishment and characterization of cul-tured epithelial cells lacking expression of ZO-1. J Biol Chem, 279, 44785-44794.
114. Van Itallie, C. M. and Anderson, J. M. 2006. Claudins and epithelial paracellular transport. Annu Rev Physiol, 68, 403-429.
115. Vera, J. C., Rivas, C. I., Fischbarg, J. et al. 1993. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature, 364, 79-82.
116. Westphal, J. K., Dorfel, M. J., Krug, S. M. et al. 2010. Tricellulin forms homomeric and het-eromeric tight junctional complexes. Cell Mol Life Sci, 67, 2057-2068.
117. Yao, S. Y., Ng, A. M., Sundaram, M. et al. 2001. Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol, 18, 161-167.
118. Yeaman, C., Grindstaff, K. K., and Nelson, W. J. 2004. Mechanism of recruiting Sec6/8 (exo-cyst) complex to the apical junctional complex during polarization of epithelial cells. J Cell Sci, 117, 559-570.
119. Yu, A. S., McCarthy, K. M., Francis, S. A. et al. 2005. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288:C1231-1241.
120. Zahraoui, A., Louvard, D., and Galli, T. 2000. Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol 151:F31-36.
121. Zeng, K., Xu, H., Mi, M. et al. 2010. Effects of taurine on glial cells apoptosis and taurine trans-porter expression in retina under diabetic conditions. Neurochem Res, 35, 1566-1574.
122. Zhang, X., Bao, S., Lai, D. et al. 2008. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes, 57, 1026-1033.